Continued action against AMR ‘essential’ for patient safety

The Medical Council has welcomed the publication of the third One Health National Action Plan to address Antimicrobial Resistance (AMR) 2026-2030, known as iNAP3.

CEO of the Medical Council, Dr Maria O’Kane, said increasing awareness of AMR is critical to protecting patients.

“According to the World Health Organisation, antimicrobial resistance is one of the top ten global threats to human health,” said Dr O’Kane. “Continued planning and action against AMR will be essential for patient safety into the future, and we welcome iNAP3 as an important step forward.” 

“For doctors, reducing AMR means ensuring that antibiotic medicines are only prescribed and administered when they are genuinely needed. Antimicrobial medicines should only be used where they are required to treat serious infections.

“For patients, not every illness requires an antibiotic, and your doctor will advise you on the most effective treatment. Avoiding unnecessary antibiotics helps protect their effectiveness for the future.”

Earlier this week, the Minister for Health, Jennifer Carroll MacNeill and Minister for Agriculture, Food and the Marine, Martin Heydon launched iNAP3.

According to the Department of Health, building “on the strong foundations” laid under iNAP1 (2017-2020) and iNAP2 (2021-2025), iNAP3 (2026-2030) “reinforces Ireland’s commitment” to tackling the growing global threat of AMR through a ;One Health approach; – recognising the interconnection between human health, animal health and the environment.

“This [AMR] threat requires a multisectoral approach across human, animal, and environment health to preserve the effectiveness of antimicrobials for future generations,” said the Health Minister.

“With this National Action Plan, iNAP3, we have demonstrated that Ireland is fully committed to a collective approach to combating antimicrobial resistance. However, its success will depend on continued commitment from every sector and from each one of us.

“Since the publication of our first iNAP plan in 2017, significant progress has been made in tackling antimicrobial resistance in the health sector, and I would like to thank all healthcare workers for their efforts in this regard.”